Although pharmacological augmentation of A20 function is mainly discussed in the context of treating inflammatory and autoimmune diseases [17], its inhibition might be beneficial to enhance immunogenicity of vaccines and the management of viral infections [14],[41]. This evidence concerns the gene TNFAIP3 and viral infectious disease.